Evaluation of contact activation of citrated equine whole blood during storage and effects of contact activation on results of recalcification-initiated thromboelastometry

Tanya M. Rossi Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, Urbana, IL 61801.

Search for other papers by Tanya M. Rossi in
Current site
Google Scholar
PubMed
Close
 DVM
,
Stephanie A. Smith Department of Biochemistry, College of Liberal Arts and Sciences, University of Illinois, Urbana, IL 61801.

Search for other papers by Stephanie A. Smith in
Current site
Google Scholar
PubMed
Close
 DVM, MS
,
Maureen A. McMichael Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, Urbana, IL 61801.

Search for other papers by Maureen A. McMichael in
Current site
Google Scholar
PubMed
Close
 DVM, MS
, and
Pamela A. Wilkins Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, Urbana, IL 61801.

Search for other papers by Pamela A. Wilkins in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

Abstract

OBJECTIVE To evaluate the degree of activation of the contact pathway in citrated equine whole blood over holding times ≤ 30 minutes and assess effects of contact activation on recalcification-initiated thromboelastometry.

ANIMALS 11 healthy adult mixed-breed horses.

PROCEDURES Blood was collected by atraumatic jugular venipuncture into prewarmed evacuated siliconized glass tubes containing citrate anticoagulant and held at 37°C for ≤ 30 minutes. Thromboelastometry was performed with an in vitro viscoelasticity (thromboelastometry) monitoring system. Factor XII and factor XI procoagulant activities were determined in contemporaneously collected platelet-poor plasma samples by assessing changes in turbidity for 1 hour at approximately 25°C, with clotting times calculated by fitting a line to the steepest segment of the absorbance curve and determining its intersection with baseline. Effect of holding time on thromboelastometry parameters and plasma enzyme activity was evaluated by repeated-measures ANOVA on ranks. Association of procoagulant activities with coagulation time was determined by Spearman rank-order correlation analysis.

RESULTS Thromboelastometry parameters (coagulation time, clot formation time, α angle, and maximum clot firmness) reflected significant increases in coagulability during the holding period. Factor XII and factor XI procoagulant activities were significantly increased at 30 minutes, compared with 2 or 10 minutes (indicating contact activation of samples), and had significant negative correlation with coagulation time.

CONCLUSIONS AND CLINICAL RELEVANCE Ex vivo activation of the contact system in equine whole blood was evident, suggesting that recalcification of blood in the absence of a trigger is not an acceptable method of assessing the hemostatic system in horses.

Abstract

OBJECTIVE To evaluate the degree of activation of the contact pathway in citrated equine whole blood over holding times ≤ 30 minutes and assess effects of contact activation on recalcification-initiated thromboelastometry.

ANIMALS 11 healthy adult mixed-breed horses.

PROCEDURES Blood was collected by atraumatic jugular venipuncture into prewarmed evacuated siliconized glass tubes containing citrate anticoagulant and held at 37°C for ≤ 30 minutes. Thromboelastometry was performed with an in vitro viscoelasticity (thromboelastometry) monitoring system. Factor XII and factor XI procoagulant activities were determined in contemporaneously collected platelet-poor plasma samples by assessing changes in turbidity for 1 hour at approximately 25°C, with clotting times calculated by fitting a line to the steepest segment of the absorbance curve and determining its intersection with baseline. Effect of holding time on thromboelastometry parameters and plasma enzyme activity was evaluated by repeated-measures ANOVA on ranks. Association of procoagulant activities with coagulation time was determined by Spearman rank-order correlation analysis.

RESULTS Thromboelastometry parameters (coagulation time, clot formation time, α angle, and maximum clot firmness) reflected significant increases in coagulability during the holding period. Factor XII and factor XI procoagulant activities were significantly increased at 30 minutes, compared with 2 or 10 minutes (indicating contact activation of samples), and had significant negative correlation with coagulation time.

CONCLUSIONS AND CLINICAL RELEVANCE Ex vivo activation of the contact system in equine whole blood was evident, suggesting that recalcification of blood in the absence of a trigger is not an acceptable method of assessing the hemostatic system in horses.

Contributor Notes

Dr. Rossi's present address is Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.

Address correspondence to Dr. Wilkins (pawilkin@illinois.edu).
  • 1. Welch RD, Watkins JP, Taylor TS, et al. Disseminated intravascular coagulation associated with colic in 23 horses (1984–1989). J Vet Intern Med 1992; 6: 2935.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2. Barton MH, Morris DD, Norton N, et al. Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia. J Vet Intern Med 1998; 12: 2635.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3. Dolente BA, Wilkins PA, Boston RC. Clinicopathologic evidence of disseminated intravascular coagulation in horses with acute colitis. J Am Vet Med Assoc 2002; 220: 10341038.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4. Pusterla N, Luff JA, Myers CJ, et al. Disseminated intravascular coagulation in a horse with Streptococcus equi subspecies zooepidemicus meningoencephalitis and interstitial pneumonia. J Vet Intern Med 2007; 21: 344347.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5. McMichael MA, Smith SA. Viscoelastic coagulation testing: technology, applications, and limitations. Vet Clin Pathol 2011; 40: 140153.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6. Tennent-Brown BS, Epstein KL, Whelchel DD, et al. Use of viscoelastic coagulation testing to monitor low molecular weight heparin administration to healthy horses. J Vet Emerg Crit Care 2013; 23: 291299.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7. Blong AE, Epstein KL, Brainard BM. In vitro effects of three formulations of hydroxyethyl starch solutions on coagulation and platelet function in horses. Am J Vet Res 2013; 74: 712720.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8. McGovern KF, Lascola KM, Smith SA, et al. Assessment of acute moderate hyperglycemia on traditional and thromboelastometry coagulation parameters in healthy adult horses. J Vet Emerg Crit Care 2012; 22: 550557.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9. McGovern KF, Lascola KM, Smith SA, et al. The effects of hyperglycemia and endotoxemia on coagulation parameters in healthy adult horses. J Vet Intern Med 2013; 27: 347353.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10. Mendez-Angulo JL, Mudge M, Zaldivar-Lopez S, et al. Thromboelastography in healthy, sick non-septic and septic neonatal foals. Aust Vet J 2011; 89: 500505.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11. Mendez-Angulo JL, Mudge MC, Vilar-Saavedra P, et al. Thromboelastography in healthy horses and horses with inflammatory gastrointestinal disorders and suspected coagulopathies. J Vet Emerg Crit Care 2010; 20: 488493.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12. Giordano A, Meazza C, Salvadori M, et al. Thromboelastometric profiles of horses affected by exercise-induced pulmonary hemorrhages. Vet Med Int [serial online] 2010; 2010: 945789. Available at: www.hindawi.com/journals/vmi/2010/945789/. Accessed Jun 19, 2014.

    • Search Google Scholar
    • Export Citation
  • 13. Epstein KL, Brainard BM, Giguere S, et al. Serial viscoelastic and traditional coagulation testing in horses with gastrointestinal disease. J Vet Emerg Crit Care 2013; 23: 504516.

    • Search Google Scholar
    • Export Citation
  • 14. Epstein KL, Brainard BM, Gomez-Ibanez SE, et al. Thrombelastography in horses with acute gastrointestinal disease. J Vet Intern Med 2011; 25: 307314.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15. Dunkel B, Chan DL, Boston R, et al. Association between hypercoagulability and decreased survival in horses with ischemic or inflammatory gastrointestinal disease. J Vet Intern Med 2010; 24: 14671474.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16. McMichael M, Smith SA, McConachie EL, et al. In-vitro hypocoagulability on whole blood thromboelastometry associated with in-vivo expansion of red cell mass in an equine model. Blood Coagul Fibrinolysis 2011; 22: 424430.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17. Epstein KL, Brainard BM, Lopes MA, et al. Thrombelastography in 26 healthy horses with and without activation by recombinant human tissue factor. J Vet Emerg Crit Care 2009; 19: 96101.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18. Paltrinieri S, Meazza C, Giordano, et al. Validation of thromboelastometry in horses. Vet Clin Pathol 2008; 37: 277285.

  • 19. Laursen SH, Andersen PH, Kjelgaard-Hansen M, et al. Comparison of components of biological variation between 3 equine thromboelastography assays. Vet Clin Pathol 2013; 42: 443450.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20. Smith SA, McMichael M, Galligan A, et al. Clot formation in canine whole blood as measured by rotational thromboelastometry is influenced by sample handling and coagulation activator. Blood Coagul Fibrinolysis 2010; 21: 692702.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21. Wiinberg B, Jensen AL, Rojkjaer R, et al. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol 2005; 34: 389393.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22. Camenzind V, Bombeli T, Seifert B, et al. Citrate storage affects Thrombelastograph analysis. Anesthesiology 2000; 92: 12421249.

  • 23. Renne T. The procoagulant and proinflammatory plasma contact system. Semin Immunopathol 2012; 34: 3141.

  • 24. Roche AM, James MF, Grocott MP, et al. Just scratching the surface: varied coagulation effects of polymer containers on TEG variables. Eur J Anaesthesiol 2006; 23: 4549.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25. Tans G, Griffin JH. Properties of sulfatides in factor-XII–dependent contact activation. Blood 1982; 59: 6975.

  • 26. Smith SA, McMichael MA, Gilor S, et al. Correlation of hematocrit, platelet concentration, and plasma coagulation factors with results of thromboelastometry in canine whole blood samples. Am J Vet Res 2012; 73: 789798.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27. Kol A, Borjesson DL. Application of thrombelastography/thromboelastometry to veterinary medicine. Vet Clin Pathol 2010; 39: 405416.

  • 28. Nielsen VG. A comparison of the Thrombelastograph and the ROTEM. Blood Coagul Fibrinolysis 2007; 18: 247252.

  • 29. Ralph AG, Brainard BM, Pittman JR, et al. Effects of rest temperature, contact activation, and sample technique on canine thrombelastography. J Vet Emerg Crit Care 2012; 22: 320326.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30. Tablin F, Walker NJ, Klein SD, et al. Animal models for studies on cold-induced platelet activation in human beings. J Lab Clin Med 2000; 135: 339346.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31. Morrissey JH. Tissue factor: a key molecule in hemostatic and nonhemostatic systems. Int J Hematol 2004; 79: 103108.

  • 32. Leclere M, Lavoie JP, Dunn M, et al. Evaluation of a modified thrombelastography assay initiated with recombinant human tissue factor in clinically healthy horses. Vet Clin Pathol 2009; 38: 462466.

    • Crossref
    • Search Google Scholar
    • Export Citation

Advertisement